What are the DSM‑5 eating disorder categories and their diagnostic criteria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DSM-5 Eating Disorder Categories and Diagnostic Criteria

The DSM-5 consolidated feeding and eating disorders into a single category and now recognizes six main eating disorders: Anorexia Nervosa (AN), Bulimia Nervosa (BN), Binge-Eating Disorder (BED), Avoidant/Restrictive Food Intake Disorder (ARFID), and two residual categories—Other Specified Feeding or Eating Disorder (OSFED) and Unspecified Feeding or Eating Disorder (UFED). 1, 2, 3

Major DSM-5 Changes from DSM-IV

The DSM-5 made substantial revisions to reduce the overuse of the "Not Otherwise Specified" category, which previously captured up to 50-68% of patients seeking treatment 3, 4, 5. These changes improved diagnostic utility and decreased reliance on residual categories from 68% to 53% 5.

Primary Eating Disorder Categories

Anorexia Nervosa (AN)

The DSM-5 modified AN criteria significantly 1, 2:

  • Removed the amenorrhea requirement (previously mandatory in DSM-IV)
  • Eliminated specific numerical weight thresholds (e.g., 85% of expected body weight)
  • Now requires: restriction of energy intake leading to significantly low body weight, intense fear of weight gain, and disturbance in body image
  • Maintains two subtypes: restricting type and binge-eating/purging type

Clinical significance: AN carries the highest mortality rate among eating disorders at 5.1 deaths per 1000 person-years—nearly 6 times higher than age-matched controls—with 25% of deaths from suicide 6.

Bulimia Nervosa (BN)

DSM-5 made minor but important changes 2, 3:

  • Lowered frequency threshold from twice weekly to once weekly for binge eating and compensatory behaviors
  • Reduced minimum duration to 3 months (from 6 months in DSM-IV research criteria)
  • Removed severity subtypes (purging vs. non-purging)
  • Core features remain: recurrent binge eating, inappropriate compensatory behaviors, and self-evaluation unduly influenced by body shape/weight

BN is associated with a 76.3% lifetime rate of depression 6.

Binge-Eating Disorder (BED)

BED was elevated from a provisional diagnosis to a formal, full-threshold eating disorder 1, 2, 3. This represents one of the most significant DSM-5 changes:

  • Requires recurrent binge eating episodes (once weekly for 3 months)
  • Marked distress regarding binge eating
  • Absence of regular compensatory behaviors (distinguishing it from BN)
  • Associated with 65.5% lifetime depression rate 6

Avoidant/Restrictive Food Intake Disorder (ARFID)

ARFID was moved from the childhood feeding disorders section and expanded 2, 3:

  • Characterized by food avoidance or restriction not driven by weight/shape concerns
  • Results in significant weight loss, nutritional deficiency, dependence on supplements, or psychosocial impairment
  • Critical distinction from AN: absence of body image disturbance or fear of weight gain
  • Applies across the lifespan, not just children

Other Specified Feeding or Eating Disorder (OSFED)

OSFED replaced "Eating Disorder Not Otherwise Specified" (EDNOS) 3, 7. It includes five specific examples:

  1. Atypical AN: meets all AN criteria except weight remains in/above normal range despite significant loss
  2. Sub-threshold BN: meets BN criteria but frequency/duration below threshold
  3. Sub-threshold BED: meets BED criteria but frequency/duration below threshold
  4. Purging disorder: recurrent purging without binge eating
  5. Night eating syndrome: recurrent nighttime eating episodes

Important caveat: OSFED presentations carry similar medical and psychiatric severity as full-threshold disorders and should not be dismissed as less serious 7.

Unspecified Feeding or Eating Disorder (UFED)

Used when clinicians choose not to specify the reason criteria aren't met or insufficient information exists for a more specific diagnosis 3.

Clinical Assessment Framework

When evaluating for eating disorders, the APA guidelines 8 mandate comprehensive assessment including:

  • Weight history: maximum/minimum weights, recent changes, BMI (or BMI percentile/Z-score for youth)
  • Eating behaviors: restrictive eating patterns, binge episodes, food avoidance, rumination, regurgitation, chewing/spitting
  • Compensatory behaviors: purging (vomiting, laxatives), driven exercise, medication misuse
  • Cognitive symptoms: percentage of time preoccupied with food/weight/shape, body image disturbance
  • Physical examination: vital signs with orthostatic measurements, signs of malnutrition or purging
  • Laboratory workup: CBC, comprehensive metabolic panel (electrolytes, liver/renal function)
  • ECG: mandatory for restrictive eating disorders, severe purging, or QTc-prolonging medications

Common Diagnostic Pitfalls

Watch for diagnostic drift: patients frequently move between eating disorder categories over time, and OSFED may represent either a distinct condition or a transitional state 7. Always assess for lifetime history of full-threshold disorders, as this impacts prognosis and treatment planning.

Don't minimize OSFED: despite being a residual category, OSFED presentations demonstrate comparable impairment, medical complications, and psychiatric comorbidity to full-threshold disorders 7.

Screen systematically: up to 50% of eating disorder cases were missed under DSM-IV criteria due to overly restrictive thresholds 4. The DSM-5 changes specifically aimed to capture these clinically significant presentations.

Related Questions

Is it reasonable to obtain a comprehensive baseline laboratory panel before initiating outpatient treatment for an eating disorder?
How is anorexia nervosa diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‑5) and managed, including criteria for inpatient medical stabilization (body mass index (BMI) <15 kg/m², severe bradycardia, hypotension, electrolyte abnormalities), re‑feeding protocol, psychotherapy (family‑based treatment (FBT), cognitive‑behavioral therapy – enhanced (CBT‑E)) and pharmacologic options (olanzapine, other atypical antipsychotics, selective serotonin reuptake inhibitors (SSRIs) after weight restoration)?
How often should a 12‑lead ECG be performed to monitor a patient with anorexia nervosa, BMI 16.9, and a resting heart rate of 32 bpm?
In a patient with a history of an eating disorder, is it appropriate to prescribe a stimulant medication?
Which antidepressants are safe for a patient with bulimia nervosa?
What are the differences between alpha‑1 (α1) and alpha‑2 (α2) adrenergic receptors, and where are each of these receptors located in the body?
How should multiple scattered lung nodules be evaluated and managed?
What is the scientific rationale for using ceftriaxone, vancomycin, and ampicillin as empiric therapy in acute bacterial meningitis?
What is the recommended dosing regimen, administration instructions, contraindications, and safety considerations for terconazole (topical azole) in treating vulvovaginal candidiasis?
What are the long-term side effects of flunarizine?
What are the differences between propofol and midazolam (Versed) for sedation and induction of anesthesia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.